0001806952 2025-08-12 2025-08-12 0001806952 1 2025-08-12 2025-08-12 iso4217:USD pure shares S-3 S-3 EX-FILING FEES 0001806952 Lyell Immunopharma, Inc. N/A N/A S-3 Lyell Immunopharma, Inc. false Equity Common Stock, par value $0.0001 per share true 3753752 10.43 39151633.36 0.0001531 5994.12 39151633.36 5994.12 0.00 0.00 5994.12 (a) Consists of an aggregate of 3,753,752 shares of the registrant's common stock, all of which were acquired by the selling stockholders in a private placement. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares of common stock being registered hereunder as a result of stock splits, stock dividends or similar transactions. (b) Pursuant to Rule 457(c), calculated on the basis of the average of the high and low prices per share of common stock reported on The Nasdaq Stock Market on August 11, 2025.